IBO (Impact BioMedical, Inc.) Stock Analysis

Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of May 21, 2026, IBO trades at $0.52 with a market cap of $58.04M and a P/E ratio of -1.52. IBO moved +4.03% today. Year to date, IBO is +3.30%; over the trailing twelve months it is -3.03%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest IBO stock research?

Impact BioMedical, Inc. (IBO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IBO moved +4.03% today.

IBO Key Metrics

Key financial metrics for IBO
MetricValue
Price$0.52
Market Cap$58.04M
P/E Ratio-1.52
EPS$-0.38
Dividend Yield0.00%
52-Week High$6.17
52-Week Low$0.36
Volume450
Avg Volume0
Revenue (TTM)$0
Net Income$-11.87M
Gross Margin0.00%

Latest IBO News

Recent IBO Insider Trades

  • Macko Todd D sold 43.40K (~$24.37K) on Mar 27, 2026.
  • Macko Todd D sold 1.60K (~$961.28) on Mar 25, 2026.
  • Grady Jason sold 50.00K (~$32.51K) on Mar 23, 2026.

IBO Analyst Consensus

IBO analyst coverage data. Average price target: $0.00.

Common questions about IBO

What can I research for IBO on Rallies?
Impact BioMedical, Inc. (IBO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IBO moved +4.03% today.
Does Rallies show live market data for IBO?
Rallies combines live market context with ticker research for IBO, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
IBO

IBO